References
- Andres A, Donovan SM, Kuhlenschmidt MS. (2009). Soy isoflavones and virus infections. J Nutr Biochem 20:563–9
- Bachmetov L, Gal-Tanamy M, Shapira A, et al. (2012). Suppression of hepatitis C virus by the flavonoid quercetin is mediated by inhibition of NS3 protease activity. J Viral Hepatitis 19:e81–8
- Berdichevsky Y, Zemel R, Bachmatov L, et al. (2003). A novel high throughput screening assay for HCV NS3 serine protease inhibitors. J Virol Methods 107:245–55
- Bi YF, Zheng XK, Feng WS, et al. (2002). Isolation and structure identification of ligan glycosides from pine needles of Pinus massoniana Lamb. Yao Xue Xue Bao 37:626–9
- Botte C, Janot C. (1996). Epidemiology of HCV infection in the general population and in blood transfusion. Nephrol Dial Transplant 11:19–21
- Bourne N, Pyles RB, Yi M, et al. (2005). Screening for hepatitis C virus antiviral activity with a cell-based secreted alkaline phosphatase reporter replicon system. Antiviral Res 67:76–82
- Cui Y, Xie H, Wang J. (2005). Potential biomedical properties of Pinus massoniana bark extract. Phytother Res 19:34–8
- Liu ZM, Yang YS, Wang XL, Wen RX. (2006). Recent progress on anti-HIV research of traditional Chinese medicine and components. Zhongguo Zhong Yao Za Zhi 31:1753–8
- McHutchison JG, Gordon SC, Schiff ER, et al. (1998). Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group. N Engl J Med 339:1485–92
- Otto GA, Puglisi JD. (2004). The pathway of HCV IRES-mediated translation initiation. Cell 119:369–80
- Rainsford KD. (2006). Influenza (“Bird Flu”), inflammation and anti-inflammatory/analgesic drugs. Inflammopharmacology 14:2–9
- Sakamoto N, Sato C, Haritani H, et al. (1993). Detection of hepatitis C viral RNA in sporadic acute non-A, non-B hepatitis by polymerase chain reaction. Its usefulness for the early diagnosis of seronegative infection. J Hepatol 17:28–33
- Sekine-Osajima Y, Sakamoto N, Nakagawa M, et al. (2009). Two flavonoids extracts from Glycyrrhizae radix inhibit in vitro hepatitis C virus replication. Hepatol Res 39:60–9
- Stephan, G. (1976). Studies on the physiological behavior of Pinus merkusii Jungh. and Pinus massoniana Lamb. Beitr Trop Landwirtsch Veterinarmed 14:71–8
- Vlietinck AJ, De Bruyne T, Apers S, Pieters LA. (1998). Plant-derived leading compounds for chemotherapy of human immunodeficiency virus (HIV) infection. Planta Med 64:97–109
- Wu C, Feng D, Ma H, et al. (2009). Effect of Pinus massoniana bark extract on IFN-gamma-induced ICAM-1 expression in HaCaT human keratinocytes. J Ethnopharmacol 122:48–53
- Xiao ZP, Peng ZY, Peng MJ, et al. (2011). Flavonoids health benefits and their molecular mechanism. Mini Rev Med Chem 11:169–77
- Zuo GY, Li ZQ, Chen LR, Xu XJ. (2005). In vitro anti-HCV activities of Saxifraga melanocentra and its related polyphenolic compounds. Antivir Chem Chemother 16:393–8